首页> 外文期刊>BMC Cardiovascular Disorders >Oral anticoagulation and self-management: analysis of the factors that determine the feasibility of using self-testing and self-management in primary care
【24h】

Oral anticoagulation and self-management: analysis of the factors that determine the feasibility of using self-testing and self-management in primary care

机译:口服抗凝和自我管理:分析决定在初级保健中使用自我测试和自我管理的可行性的因素

获取原文
           

摘要

Background The skills of patients on oral anticoagulants are critical for achieving good outcomes with this treatment. Self-management, or the capacity of patients to control their INR level and adjust their treatment, is an effective strategy of treatment. Capacity of patients to self manage is determined by a range of factors. The identification of these factors would improve the design of self management programmes and in turn increase the number of patients able to self-manage. The objective of our study is to identify those factors that determine the ability of patients on oral anticoagulant therapy to achieve self-management of their treatment. Design This will be a three year quasi- experimental prospective study with a control group. 333 patients on anticoagulant therapy from five health centres of the Basque Health Service are to be followed up for a period of six months each after the intervention, to assess their ability to self-test and self-manage. The intervention will consist of a patient training programme involving the provision of information and practical training concerning their condition and its treatment, as well as how to use a portable blood coagulation monitoring device and adjust their anticoagulant dose. Discussion The ease-of-use of this technique lead us to believe that self-management is feasible and will represent an innovative advance that should have a substantial impact on the quality of life of this patients and their families as well as on the health care provision systems. Trial registration Osakidetza Protocol Record ISCIII-11/02285, Oral anticoagulation and self-management, ClinicalTrials.gov Identifier: NCT01878539
机译:背景技术口服抗凝剂患者的技能对于通过这种治疗取得良好的效果至关重要。自我管理或患者控制INR水平和调整治疗的能力是一种有效的治疗策略。患者自我管理的能力取决于一系列因素。这些因素的识别将改善自我管理计划的设计,进而增加能够自我管理的患者人数。我们研究的目的是确定那些决定患者口服抗凝治疗药物实现自我管理的能力的因素。设计这是与对照组进行的为期三年的准实验前瞻性研究。来自巴斯克卫生局五个卫生中心的333名接受抗凝治疗的患者应在干预后每6个月进行一次随访,以评估其自我测试和自我管理的能力。干预措施将包括一个患者培训计划,该计划包括提供有关患者状况及其治疗的信息和实践培训,以及如何使用便携式凝血监测设备并调整其抗凝剂剂量。讨论这种技术的易用性使我们相信自我管理是可行的,并且将代表一项创新进步,应该对该患者及其家人的生活质量以及卫生保健产生重大影响。供应系统。试验注册Osakidetza协议记录ISCIII-11 / 02285,口服抗凝和自我管理,ClinicalTrials.gov标识符:NCT01878539

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号